日水製薬(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4550/E00971Nissui Pharmaceutical Co., Ltd
公表日公表担保貸付残高前週比借入残高（自己）前週比借入残高（転貸）前週比
2018/01/26日証協無担保15,000株0%2,800株-3.45%107,271株-1.47%
2018/01/26日証協有担保43,500株+7.14%5,100株-1.92%30,200株+11.03%
2018/01/19日証協無担保15,000株+1.35%2,900株-6.45%108,868株-0.36%
2018/01/19日証協有担保40,600株+5.45%5,200株0%27,200株+10.12%
2018/01/12日証協無担保14,800株0%3,100株-88.93%109,258株+1.11%
2018/01/12日証協有担保38,500株+1.85%5,200株0%24,700株+2.49%
2018/01/05日証協無担保14,800株0%28,000株0%108,058株+0.47%
2018/01/05日証協有担保37,800株-9.35%5,200株0%24,100株+2.12%
2017/12/29日証協無担保14,800株0%28,000株+1020%107,557株+0.38%
2017/12/29日証協有担保41,700株+15.83%5,200株0%23,600株+2.16%
2017/12/22日証協無担保14,800株0%2,500株+56.25%107,153株0%
2017/12/22日証協有担保36,000株-0.28%5,200株-18.75%23,100株-10.81%
2017/12/15日証協無担保14,800株0%1,600株0%107,158株-0.35%
2017/12/15日証協有担保36,100株-8.84%6,400株0%25,900株-7.17%
2017/12/08日証協無担保14,800株-14.94%0株0%107,538株-1.56%
2017/12/08日証協有担保39,600株-13.73%6,400株+16.36%27,900株-15.96%
2017/12/01日証協無担保17,400株-13.86%0株0%109,238株+0.18%
2017/12/01日証協有担保45,900株+0.88%5,500株+1.85%33,200株+2.47%
2017/11/24日証協無担保20,200株-3.35%0株0%109,038株-0.37%
2017/11/24日証協有担保45,500株-0.66%5,400株-11.48%32,400株-7.16%
2017/11/17日証協無担保20,900株0%0株0%109,438株+0.18%
2017/11/17日証協有担保45,800株+2.23%6,100株-1.61%34,900株+1.45%
2017/11/10日証協無担保20,900株0%0株0%109,238株+0.27%
2017/11/10日証協有担保44,800株+0.67%6,200株-7.46%34,400株+1.47%
2017/11/02日証協無担保20,900株0%0株0%108,939株+0.74%
2017/11/02日証協有担保44,500株+0.45%6,700株+1.52%33,900株+1.8%
2017/10/27日証協無担保20,900株0%0株0%108,139株-0.46%
2017/10/27日証協有担保44,300株+1.37%6,600株+1000%33,300株-15.27%
2017/10/20日証協無担保20,900株0%0株0%108,636株-1.81%
2017/10/20日証協有担保43,700株+0.92%600株0%39,300株0%
2017/10/13日証協無担保20,900株0%0株0%110,636株+1.1%
2017/10/13日証協有担保43,300株-0.46%600株0%39,300株-2.24%
2017/10/06日証協無担保20,900株-3.24%0株0%109,436株+8305.22%
2017/10/06日証協有担保43,500株-37.05%600株-95.56%40,200株-39%
2017/09/29日証協無担保21,600株0%0株0%1,302株-98.75%
2017/09/29日証協有担保69,100株+66.51%13,500株-28.95%65,900株+111.9%
2017/09/22日証協無担保0株0%0株-100%104,339株-5.18%
2017/09/22日証協有担保41,500株+0.97%19,000株0%31,100株-0.96%

※株式分割は考慮していませんのでご注意ください。

Page Top